Cardiac arrhythmia: in vivo screening in the zebrafish to overcome complexity in drug discovery

Bibliography

• Wellens HJ. Cardiac arrhythmias: the quest for a cure: a historical perspective. J Am Coll Cardiol 2004;44(6):1155-63
   PubMed Web of Science ®Google Scholar
• Roden DM. Drug-induced prolongation of the QT interval. N Engl J Med 2004;350(10):1013-22
   PubMed Web of Science ®Google Scholar
• The cardiac arrhythmia suppression trial. N Engl J Med 1989;321(25):1754-6
   PubMedGoogle Scholar
• Waldo AL. A perspective on antiarrhythmic drug therapy to treat atrial fibrillation: there remains an unmet need. Am Heart J 2006;151(4):771-8
   PubMed Web of Science ®Google Scholar
• Waldo AL. Mechanisms of atrial fibrillation. J Cardiovasc Electrophysiol 2003;14(Suppl 12):S267-74
   PubMed Web of Science ®Google Scholar
• Eckardt L, Haverkamp W, Johna R, Arrhythmias in heart failure: current concepts of mechanisms and therapy. J Cardiovasc Electrophysiol 2000;11(1):106-17
   PubMed Web of Science ®Google Scholar
• Roden DM. Mechanisms and management of proarrhythmia. Am J Cardiol 1998;82(4A):49I-57I
   PubMed Web of Science ®Google Scholar
• Ruskin JN. The cardiac arrhythmia suppression trial (CAST). N Engl J Med 1989;321(6):386-8
   PubMed Web of Science ®Google Scholar
• Spooner PM, Albert C, Benjamin EJ, Sudden cardiac death, genes, and arrhythmogenesis: consideration of new population and mechanistic approaches from a national heart, lung, and blood institute workshop, part I. Circulation 2001;103(19):2361-4
   PubMed Web of Science ®Google Scholar
• MacRae CA, Ellinor PT. Genetic screening and risk assessment in hypertrophic cardiomyopathy. J Am Coll Cardiol 2004;44(12):2326-8
   PubMed Web of Science ®Google Scholar
• Vatta M, Dumaine R, Varghese G, Genetic and biophysical basis of sudden unexplained nocturnal death syndrome (SUNDS), a disease allelic to Brugada syndrome. Hum Mol Genet 2002;11(3):337-45
   PubMed Web of Science ®Google Scholar
• Keating MT, Sanguinetti MC. Molecular and cellular mechanisms of cardiac arrhythmias. Cell 2001;104(4):569-80
   PubMed Web of Science ®Google Scholar
• Lloyd-Jones DM, Wang TJ, Leip EP, Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation 2004;110(9):1042-6
   PubMed Web of Science ®Google Scholar
• Shah M, Akar FG, Tomaselli GF. Molecular basis of arrhythmias. Circulation 2005;112(16):2517-29
   PubMed Web of Science ®Google Scholar
• Ho CY, Sweitzer NK, McDonough B, Assessment of diastolic function with Doppler tissue imaging to predict genotype in preclinical hypertrophic cardiomyopathy. Circulation 2002;105(25):2992-7
   PubMed Web of Science ®Google Scholar
• Nerbonne JM, Kass RS. Molecular physiology of cardiac repolarization. Physiol Rev 2005;85(4):1205-53
   PubMed Web of Science ®Google Scholar
• Roden DM, Balser JR, George AL Jr, Cardiac ion channels. Annu Rev Physiol 2002;64:431-75
   PubMed Web of Science ®Google Scholar
• Salama G, London B. Mouse models of long QT syndrome. J Physiol 2007;578(Pt 1):43-53
   PubMed Web of Science ®Google Scholar
• Casimiro MC, Knollmann BC, Yamoah EN, Targeted point mutagenesis of mouse Kcnq1: phenotypic analysis of mice with point mutations that cause Romano-Ward syndrome in humans. Genomics 2004;84(3):555-64
   PubMed Web of Science ®Google Scholar
• Emmi A, Wenzel HJ, Schwartzkroin PA, Do glia have heart?. Expression and functional role for ether-a-go-go currents in hippocampal astrocytes. J Neurosci 2000;20(10):3915-25
   PubMed Web of Science ®Google Scholar
• Priori SG, Napolitano C, Schwartz PJ. Low penetrance in the long-QT syndrome: clinical impact. Circulation 1999;99(4):529-33
   PubMed Web of Science ®Google Scholar
• Koren G. Electrical remodeling and arrhythmias in long-QT syndrome: lessons from genetic models in mice. Ann Med 2004;36(Suppl 1):22-7
   PubMedGoogle Scholar
• Ali RH, Zareba W, Moss AJ, Clinical and genetic variables associated with acute arousal and nonarousal-related cardiac events among subjects with long QT syndrome. Am J Cardiol 2000;85(4):457-61
   PubMed Web of Science ®Google Scholar
• Schwartz PJ, Priori SG, Spazzolini C, Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation 2001;103(1):89-95
   PubMed Web of Science ®Google Scholar
• Chen YH, Xu SJ, Bendahhou S, KCNQ1 gain-of-function mutation in familial atrial fibrillation. Science 2003;299(5604):251-4
   PubMed Web of Science ®Google Scholar
• Otway R, Vandenberg JI, Guo G, Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? J Am Coll Cardiol 2007;49(5):578-86
   PubMed Web of Science ®Google Scholar
• MacRae CA. Closer look at genetic testing in long-QT syndrome: will DNA diagnostics ever be enough? Circulation 2009;120(18):1745-8
   PubMed Web of Science ®Google Scholar
• Jentsch TJ, Hubner CA, Fuhrmann JC. Ion channels: function unravelled by dysfunction. Nat Cell Biol 2004;6(11):1039-47
   PubMed Web of Science ®Google Scholar
• Ficker E, Dennis AT, Wang L, Role of the cytosolic chaperones Hsp70 and Hsp90 in maturation of the cardiac potassium channel HERG. Circ Res 2003;92(12):e87-100
   PubMed Web of Science ®Google Scholar
• Mohler PJ, Schott JJ, Gramolini AO, Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death. Nature 2003;421(6923):634-9
   PubMed Web of Science ®Google Scholar
• Mohler PJ, Splawski I, Napolitano C, A cardiac arrhythmia syndrome caused by loss of ankyrin-B function. Proc Natl Acad Sci USA 2004;101(24):9137-42
   PubMed Web of Science ®Google Scholar
• Vatta M, Ackerman MJ, Ye B, Mutant caveolin-3 induces persistent late sodium current and is associated with long-QT syndrome. Circulation 2006;114(20):2104-12
   PubMed Web of Science ®Google Scholar
• Petrecca K, Atanasiu R, Akhavan A, N-linked glycosylation sites determine HERG channel surface membrane expression. J Physiol 1999;515(Pt 1):41-8
   PubMed Web of Science ®Google Scholar
• Furutani M, Trudeau MC, Hagiwara N, Novel mechanism associated with an inherited cardiac arrhythmia: defective protein trafficking by the mutant HERG (G601S) potassium channel. Circulation 1999;99(17):2290-4
   PubMed Web of Science ®Google Scholar
• Kiss E, Nagy P, Balogh A, Cytometry of raft and caveola membrane microdomains: from flow and imaging techniques to high throughput screening assays. Cytometry A 2008;73(7):599-614
   PubMedGoogle Scholar
• Milan DJ, Kim AM, Winterfield JR, Drug-sensitized zebrafish screen identifies multiple genes, including GINS3, as regulators of myocardial repolarization. Circulation 2009;120(7):553-9
   PubMed Web of Science ®Google Scholar
• Corrado D, Basso C, Thiene G, Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study. J Am Coll Cardiol 1997;30(6):1512-20
   PubMed Web of Science ®Google Scholar
• Sen-Chowdhry S, Syrris P, McKenna WJ. Desmoplakin disease in arrhythmogenic right ventricular cardiomyopathy: early genotype-phenotype studies. Eur Heart J 2005;26(16):1582-4
   PubMed Web of Science ®Google Scholar
• Coonar AS, Protonotarios N, Tsatsopoulou A, Gene for arrhythmogenic right ventricular cardiomyopathy with diffuse nonepidermolytic palmoplantar keratoderma and woolly hair (Naxos disease) maps to 17q21. Circulation 1998;97(20):2049-58
   PubMed Web of Science ®Google Scholar
• Rampazzo A, Nava A, Malacrida S, Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular cardiomyopathy. Am J Hum Genet 2002;71(5):1200-6
   PubMed Web of Science ®Google Scholar
• Gerull B, Heuser A, Wichter T, Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy. Nat Genet 2004;36(11):1162-4
   PubMed Web of Science ®Google Scholar
• Syrris P, Ward D, Evans A, Arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in the desmosomal gene desmocollin-2. Am J Hum Genet 2006;79(5):978-84
   PubMed Web of Science ®Google Scholar
• Heuser A, Plovie ER, Ellinor PT, Mutant desmocollin-2 causes arrhythmogenic right ventricular cardiomyopathy. Am J Hum Genet 2006;79(6):1081-8
   PubMed Web of Science ®Google Scholar
• Asimaki A, Syrris P, Wichter T, A novel dominant mutation in plakoglobin causes arrhythmogenic right ventricular cardiomyopathy. Am J Hum Genet 2007;81(5):964-73
   PubMed Web of Science ®Google Scholar
• Garcia-Gras E, Lombardi R, Giocondo MJ, Suppression of canonical Wnt/beta-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy. J Clin Invest 2006;116(7):2012-21
   PubMed Web of Science ®Google Scholar
• Asimaki A, Tandri H, Huang H, A new diagnostic test for arrhythmogenic right ventricular cardiomyopathy. N Engl J Med 2009;360(11):1075-84
   PubMed Web of Science ®Google Scholar
• Nattel S, Shiroshita-Takeshita A, Cardin S, Mechanisms of atrial remodeling and clinical relevance. Curr Opin Cardiol 2005;20(1):21-5
   PubMed Web of Science ®Google Scholar
• Brundel BJ, Henning RH, Kampinga HH, Molecular mechanisms of remodeling in human atrial fibrillation. Cardiovasc Res 2002;54(2):315-24
   PubMed Web of Science ®Google Scholar
• Sack MN, Kelly DP. The energy substrate switch during development of heart failure: gene regulatory mechanisms [review]. Int J Mol Med 1998;1(1):17-24
   PubMed Web of Science ®Google Scholar
• Heineke J, Molkentin JD. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol 2006;7(8):589-600
   PubMed Web of Science ®Google Scholar
• McNally EM, Pytel P. Muscle diseases: the muscular dystrophies. Annu Rev Pathol 2007;2:87-109
   PubMed Web of Science ®Google Scholar
• Kass RS, Kurokawa J, Marx SO, Leucine/isoleucine zipper coordination of ion channel macromolecular signaling complexes in the heart. Roles in inherited arrhythmias. Trends Cardiovasc Med 2003;13(2):52-6
   PubMed Web of Science ®Google Scholar
• Berridge MJ, Bootman MD, Roderick HL. Calcium signalling: dynamics, homeostasis and remodelling. Nat Rev Mol Cell Biol 2003;4(7):517-29
   PubMed Web of Science ®Google Scholar
• Feillet F, Steinmann G, Vianey-Saban C, Adult presentation of MCAD deficiency revealed by coma and severe arrythmias. Intensive Care Med 2003;29(9):1594-7
   PubMed Web of Science ®Google Scholar
• Antzelevitch C, Fish J. Electrical heterogeneity within the ventricular wall. Basic Res Cardiol 2001;96(6):517-27
   PubMed Web of Science ®Google Scholar
• Christoffels VM, Burch JB, Moorman AF. Architectural plan for the heart: early patterning and delineation of the chambers and the nodes. Trends Cardiovasc Med 2004;14(8):301-7
   PubMed Web of Science ®Google Scholar
• de Bakker JM, van Capelle FJ, Janse MJ, Reentry as a cause of ventricular tachycardia in patients with chronic ischemic heart disease: electrophysiologic and anatomic correlation. Circulation 1988;77(3):589-606
   PubMed Web of Science ®Google Scholar
• van der Merwe PL, Rose AG, van der Walt JJ, Progressive familial heart block type I. Clinical and pathological observations. S Afr Med J 1991;80(1):34-8
   PubMed Web of Science ®Google Scholar
• Brink PA, Ferreira A, Moolman JC, Gene for progressive familial heart block type I maps to chromosome 19q13. Circulation 1995;91(6):1633-40
   PubMed Web of Science ®Google Scholar
• Brugada R, Brugada J, Antzelevitch C, Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts. Circulation 2000;101(5):510-15
   PubMed Web of Science ®Google Scholar
• Weiss R, Barmada MM, Nguyen T, Clinical and molecular heterogeneity in the Brugada syndrome: a novel gene locus on chromosome 3. Circulation 2002;105(6):707-13
   PubMed Web of Science ®Google Scholar
• Antzelevitch C, Yan GX, Shimizu W. Transmural dispersion of repolarization and arrhythmogenicity: the Brugada syndrome versus the long QT syndrome. J Electrocardiol 1999;32(Suppl):158-65
   PubMedGoogle Scholar
• Costantini DL, Arruda EP, Agarwal P, The homeodomain transcription factor Irx5 establishes the mouse cardiac ventricular repolarization gradient. Cell 2005;123(2):347-58
   PubMed Web of Science ®Google Scholar
• Heydemann A, Huber JM, Kakkar R, Functional nitric oxide synthase mislocalization in cardiomyopathy. J Mol Cell Cardiol 2004;36(2):213-23
   PubMed Web of Science ®Google Scholar
• Frustaci A, Chimenti C, Bellocci F, Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 1997;96(4):1180-4
   PubMed Web of Science ®Google Scholar
• Issac TT, Dokainish H, Lakkis NM. Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data. J Am Coll Cardiol 2007;50(21):2021-8
   PubMed Web of Science ®Google Scholar
• Ramos-Mondragon R, Galindo CA, Avila G. Role of TGF-beta on cardiac structural and electrical remodeling. Vasc Health Risk Manag 2008;4(6):1289-300
   PubMedGoogle Scholar
• Lin CS, Pan CH. Regulatory mechanisms of atrial fibrotic remodeling in atrial fibrillation. Cell Mol Life Sci 2008;65(10):1489-508
   PubMed Web of Science ®Google Scholar
• Ellinor PT, Sasse-Klaassen S, Probst S, A novel locus for dilated cardiomyopathy, diffuse myocardial fibrosis, and sudden death on chromosome 10q25-26. J Am Coll Cardiol 2006;48(1):106-11
   PubMed Web of Science ®Google Scholar
• Weber KT. Fibrosis and hypertensive heart disease. Curr Opin Cardiol 2000;15(4):264-72
   PubMed Web of Science ®Google Scholar
• Wu SM, Chien KR, Mummery C. Origins and fates of cardiovascular progenitor cells. Cell 2008;132(4):537-43
   PubMed Web of Science ®Google Scholar
• Ahuja P, Sdek P, MacLellan WR. Cardiac myocyte cell cycle control in development, disease, and regeneration. Physiol Rev 2007;87(2):521-44
   PubMed Web of Science ®Google Scholar
• Milan DJ, MacRae CA. Animal models for arrhythmias. Cardiovasc Res 2005;67(3):426-37
   PubMed Web of Science ®Google Scholar
• Roden DM, Altman RB, Benowitz NL, Pharmacogenomics: challenges and opportunities. Ann Intern Med 2006;145(10):749-57
   PubMed Web of Science ®Google Scholar
• Rutitzky B, Girotti AL, Rosenbaum MB. Efficacy of chronic amiodarone therapy in patients with variant angina pectoris and inhibition of ergonovine coronary constriction. Am Heart J 1982;103(1):38-43
   PubMed Web of Science ®Google Scholar
• Zhang S, Zhou Z, Gong Q, Mechanism of block and identification of the verapamil binding domain to HERG potassium channels. Circ Res 1999;84(9):989-98
   PubMed Web of Science ®Google Scholar
• Kaski JC, Girotti LA, Elizari MV, Efficacy of amiodarone during long-term treatment of potentially dangerous ventricular arrhythmias in patients with chronic stable ischemic heart disease. Am Heart J 1984;107(4):648-55
   PubMed Web of Science ®Google Scholar
• Strange K. The end of “naive reductionism”: rise of systems biology or renaissance of physiology? Am J Physiol Cell Physiol 2005;288(5):C968-74
   PubMed Web of Science ®Google Scholar
• Ge H, Walhout AJ, Vidal M. Integrating ‘omic’ information: a bridge between genomics and systems biology. Trends Genet 2003;19(10):551-60
   PubMed Web of Science ®Google Scholar
• Giallourakis C, Henson C, Reich M, Disease gene discovery through integrative genomics. Annu Rev Genomics Hum Genet 2005;6:381-406
   PubMed Web of Science ®Google Scholar
• Li S, Armstrong CM, Bertin N, A map of the interactome network of the metazoan C. elegans. Science 2004;303(5657):540-3
   PubMed Web of Science ®Google Scholar
• Rudy Y. From genome to physiome: integrative models of cardiac excitation. Ann Biomed Eng 2000;28(8):945-50
   PubMed Web of Science ®Google Scholar
• Verrier RL, Antzelevitch C. Autonomic aspects of arrhythmogenesis: the enduring and the new. Curr Opin Cardiol 2004;19(1):2-11
   PubMed Web of Science ®Google Scholar
• Berger SI, Ma'ayan A, Iyengar R. Systems pharmacology of arrhythmias. Sci Signal 2010;3(118):ra30
   PubMedGoogle Scholar
• Cheng CS, Alderman D, Kwash J, A high-throughput HERG potassium channel function assay: an old assay with a new look. Drug Dev Ind Pharm 2002;28(2):177-91
   PubMed Web of Science ®Google Scholar
• Casimiro MC, Knollmann BC, Ebert SN, Targeted disruption of the Kcnq1 gene produces a mouse model of Jervell and Lange-Nielsen Syndrome. Proc Natl Acad Sci USA 2001;98(5):2526-31
   PubMed Web of Science ®Google Scholar
• Nerbonne JM. Studying cardiac arrhythmias in the mouse – a reasonable model for probing mechanisms? Trends Cardiovasc Med 2004;14(3):83-93
   PubMed Web of Science ®Google Scholar
• Yamanaka S. Induction of pluripotent stem cells from mouse fibroblasts by four transcription factors. Cell Prolif 2008;41(Suppl 1):51-6
   PubMed Web of Science ®Google Scholar
• Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126(4):663-76
   PubMed Web of Science ®Google Scholar
• Domian IJ, Chiravuri M, van der Meer P, Generation of functional ventricular heart muscle from mouse ventricular progenitor cells. Science 2009;326(5951):426-9
   PubMed Web of Science ®Google Scholar
• Potet F, Petersen CI, Boutaud O, Genetic screening in C. elegans identifies rho-GTPase activating protein 6 as novel HERG regulator. J Mol Cell Cardiol 2009;46(2):257-67
   PubMed Web of Science ®Google Scholar
• Langheinrich U. Zebrafish: a new model on the pharmaceutical catwalk. Bioessays 2003;25(9):904-12
   PubMed Web of Science ®Google Scholar
• Lieschke GJ, Currie PD. Animal models of human disease: zebrafish swim into view. Nat Rev Genet 2007;8(5):353-67
   PubMed Web of Science ®Google Scholar
• Zon LI, Peterson RT. In vivo drug discovery in the zebrafish. Nat Rev Drug Discov 2005;4(1):35-44
   PubMed Web of Science ®Google Scholar
• MacRae CA, Peterson RT. Zebrafish-based small molecule discovery. Chem Biol 2003;10(10):901-8
   PubMed Web of Science ®Google Scholar
• Burns CG, Milan DJ, Grande EJ, High-throughput assay for small molecules that modulate zebrafish embryonic heart rate. Nat Chem Biol 2005;1(5):263-4
   PubMed Web of Science ®Google Scholar
• Milan DJ, Peterson TA, Ruskin JN, Drugs that induce repolarization abnormalities cause bradycardia in zebrafish. Circulation 2003;107(10):1355-8
   PubMed Web of Science ®Google Scholar
• Fishman MC. Genomics. Zebrafish – the canonical vertebrate. Science 2001;294(5545):1290-1
   PubMed Web of Science ®Google Scholar
• Nasevicius A, Ekker SC. Effective targeted gene ‘knockdown’ in zebrafish. Nat Genet 2000;26(2):216-20
   PubMed Web of Science ®Google Scholar
• Meng X, Noyes MB, Zhu LJ, Targeted gene inactivation in zebrafish using engineered zinc-finger nucleases. Nat Biotechnol 2008;26(6):695-701
   PubMed Web of Science ®Google Scholar
• Driever W, Solnica-Krezel L, Schier AF, A genetic screen for mutations affecting embryogenesis in zebrafish. Development 1996;123:37-46
   PubMed Web of Science ®Google Scholar
• Kokel D, Bryan J, Laggner C, Rapid behavior-based identification of neuroactive small molecules in the zebrafish. Nat Chem Biol 2010;6(3):231-7
   PubMed Web of Science ®Google Scholar
• Yeh JR, Munson KM, Chao YL, AML1-ETO reprograms hematopoietic cell fate by downregulating scl expression. Development 2008;135(2):401-10
   PubMed Web of Science ®Google Scholar
• Peterson RT, Shaw SY, Peterson TA, Chemical suppression of a genetic mutation in a zebrafish model of aortic coarctation. Nat Biotechnol 2004;22(5):595-9
   PubMed Web of Science ®Google Scholar
• Cuny GD, Yu PB, Laha JK, Structure-activity relationship study of bone morphogenetic protein (BMP) signaling inhibitors. Bioorg Med Chem Lett 2008;18(15):4388-92
   PubMed Web of Science ®Google Scholar
• Lee JS, Yu Q, Shin JT, Klf2 is an essential regulator of vascular hemodynamic forces in vivo. Dev Cell 2006;11(6):845-57
   PubMed Web of Science ®Google Scholar
• Langheinrich U, Vacun G, Wagner T. Zebrafish embryos express an orthologue of HERG and are sensitive toward a range of QT-prolonging drugs inducing severe arrhythmia. Toxicol Appl Pharmacol 2003;193(3):370-82
   PubMed Web of Science ®Google Scholar
• Baker K, Warren KS, Yellen G, Defective “pacemaker” current (Ih) in a zebrafish mutant with a slow heart rate. Proc Natl Acad Sci USA 1997;94(9):4554-9
   PubMed Web of Science ®Google Scholar
• Milan DJ, Jones IL, Ellinor PT, In vivo recording of adult zebrafish electrocardiogram and assessment of drug-induced QT prolongation. Am J Physiol Heart Circ Physiol 2006;291(1):H269-73
   PubMed Web of Science ®Google Scholar
• Shin JT, Pomerantsev EV, Mably JD, High-resolution cardiovascular function confirms functional orthology of myocardial contractility pathways in zebrafish. Physiol Genomics 2010. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Shah RR, Hondeghem LM. Refining detection of drug-induced proarrhythmia: QT interval and TRIaD. Heart Rhythm 2005;2(7):758-72
   PubMed Web of Science ®Google Scholar
• Lupoglazoff JM, Cheav T, Baroudi G, Homozygous SCN5A mutation in long-QT syndrome with functional two-to-one atrioventricular block. Circ Res 2001;89(2):E16-21
   PubMed Web of Science ®Google Scholar
• Ho SY, Thorpe JL, Deng Y, Lipid metabolism in zebrafish. Methods Cell Biol 2004;76:87-108
   PubMed Web of Science ®Google Scholar
• Weinstein BM. What guides early embryonic blood vessel formation? Dev Dyn 1999;215(1):2-11
   PubMed Web of Science ®Google Scholar
• Shin JT, Fishman MC. From Zebrafish to human: modular medical models. Annu Rev Genomics Hum Genet 2002;3:311-40
   PubMed Web of Science ®Google Scholar
• Yu PB, Deng DY, Lai CS, BMP type I receptor inhibition reduces heterotopic [corrected] ossification. Nat Med 2008;14(12):1363-9
   PubMed Web of Science ®Google Scholar
• Berghmans S, Butler P, Goldsmith P, Zebrafish based assays for the assessment of cardiac, visual and gut function – potential safety screens for early drug discovery. J Pharmacol Toxicol Methods 2008;58(1):59-68
   PubMedGoogle Scholar